Home | Welcome to Contract Pharma   
Last Updated Saturday, May 30 2015

Print

Search Results for 'Development'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Contract Service Directory Companies

View All Companies »


Contract Service Directory Categories

View All Categories »


Search Results:

Published May 29, 2015
Trexler and Su to lead commercial and medical strategy Read More »
Published May 29, 2015
Will utilize NanoString’s nCounter Analysis to optimize gene expression signatures Read More »
Published May 29, 2015
43,000 sq.-ft. headquarters in Shanghai now has approximately 300 employees Read More »
Published May 29, 2015
Will evaluate AZ’s investigational anti-PD-L1 with Lilly’s CYRAMZA Read More »
Published May 27, 2015
Bedford to bolster branding and marketing ops post Harlan acquisition Read More »
Published May 27, 2015
Aims to simplify patient randomization and clinical supply management Read More »
Published May 27, 2015
Provides access to Quintiles’ processes and platforms Read More »
Published May 27, 2015
To explore late-stage assets in combination with Imbruvica Read More »
Published May 27, 2015
Believes events of suicidal ideation and behavior likely to restrict labeling Read More »
Published May 22, 2015
Expands protein detection franchise Read More »
Published May 22, 2015
To provide aseptic and low bioburden clean room dispensing of bulk materials Read More »
Published May 21, 2015
Former director, global regulatory strategy for Bristol-Myers Squibb Read More »
Published May 21, 2015
Selected for a highly specialized vaccine fill/finish project Read More »
Published May 21, 2015
Biomay to apply VTU Pichia strains for the production of recombinant allergens Read More »
Published May 20, 2015
Will use Achillion assets to develop pan-genotypic oral regimen for HCV Read More »
Published May 20, 2015
GEA Niro Mobile Minor enhances solutions for poorly soluble compounds Read More »
Manager/Senior Manager Business Development
Published May 19, 2015
This position is responsible for developing and maintaining business relationships with existing and potential clients. Read More »
Published May 19, 2015
Bolsters liquid generics portfolio Read More »
Published May 19, 2015
Company continues to support its growing biologics portfolio Read More »
Published May 19, 2015
Will evaluate combinations of Advaxis’s Lm-LLO immunotherapy technology and Sorrento’s immunomodulatory antibodies Read More »
Published May 18, 2015
Increases funds for R&D efforts for Structured Organic Particulate Systems Read More »
Published May 18, 2015
Phase I drug demonstrates oral bioavailability, target inhibition, safety and tolerability Read More »
Published May 18, 2015
Aims to target underlying causes of MS disease progression Read More »
Published May 15, 2015
Publishes results from Enabled-First-in-Human program conducted for the Janssen WAVE Early Development unit. Read More »
Published May 14, 2015
AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Labs Read More »
Published May 14, 2015
(Irvine, CA) (Job Number: 151010) Read More »
Published May 14, 2015
Biologics Services revenues up 75% in the quarter Read More »
Published May 14, 2015
Will combine biotech capabilities to develop therapies for autoimmune disorders Read More »
Published May 14, 2015
Catalent to provide biomanufacturing activities for MANF protein Read More »
2015 Annual Outsourcing Survey
By Tim Wright, Editor
Published May 13, 2015
Herein are the results of our 2015 Annual Outsourcing Survey, where we call on you, the readers. Read More »
Published May 13, 2015
Offers improved compaction properties in direct compression applications Read More »
Published May 13, 2015
Will deploy inspection and quality control solutions; framework established for co-development projects Read More »
Published May 13, 2015
Saves pharmaceutical manufacturers time and money by determining ideal packaging needs Read More »
Published May 13, 2015
Group initiates a prime boost study of Ebola vaccine candidates Read More »
Published May 12, 2015
Will collaborate to identify and validate tumor targets and corresponding TCRs in cancer Read More »
Published May 12, 2015
Secures exclusive option to acquire the company following a Phase II trial of recAP Read More »
Published May 12, 2015
Gains softgel manufacturing technology Read More »
Published May 12, 2015
To open new R&D centers in Asia Pacific and in Europe Read More »
Published May 12, 2015
Gains leading biologic treatment and oncology infrastructure for $900M Read More »
Published May 11, 2015
Adds approximately 60 on-market products and nearly 70 R&D pipeline programs Read More »
Published May 11, 2015
The new facility has already been deployed to manufacture a Humira biosimilar candidate in an upcoming Phase III trial Read More »
Published May 11, 2015
Firms will co-develop Elasmogen's soloMER technology Read More »
Published May 11, 2015
Clinical research specialists Accenture, Aptus, Boyds and KJC bring strong experience to CTDs orphan drug program Read More »
Published May 8, 2015
Patheon is fully committed to the development, optimization, and scale-up of prefilled syringes and cartridges. Our experience spans a large number of projects for a wide variety of large and small molecules.… Read More »
Published May 8, 2015
Patheon's Monza and Ferentino facilities are sterile manufacturing centers of excellence. This brochure highlights the extensive range of component formats that are available, allowing for the flexibility of additional formats to meet your needs.… Read More »
Published May 8, 2015
Patheon offers fully integrated lyophilized product development services and commercial manufacturing for a wide range of molecule types. This sell sheet gives an overview of these specialized capabilities.… Read More »
Published May 8, 2015
With a fully integrated network of U.S. FDA-approved sites across Europe, Patheon can satisfy sterile product needs from 1 to 10,000 units. This sell sheet highlights the breadth of capabilities from clinical development to process scale-up and comme… Read More »
Published May 8, 2015
With the experience of nearly 400 highly potent compounds, you can count on Patheon for the development and manufacturing of these complex pharmaceuticals, including hormones and compounds with OELs in the nano gram per cubic range.… Read More »
Published May 8, 2015
Patheon has developed over 80 large molecule dose forms. This sell sheet highlights Patheon's extensive experience and capabilities ranging from early formulation development through to product commercialization of both liquid and lyophilized product… Read More »
Published May 8, 2015
Patheon’s Pediatric Services are dedicated to developing palatable formulations, including oral liquids, chewable tablets, dispersible tablets, sachets, oral disintegrating tablets and softgels. This sell sheet discusses the interactions between AP… Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On